葫芦影业

Dr Natalie Barratt joined the Clinical Infection Research Group in July 2022. She is currently investigating human serum and mucosal humoral immune responses to pathogens of global health importance, particularly SARS-CoV-2, in clinical vaccine trials and cohort studies. She is a microbiologist with expertise in bacterial virulence mechanisms, microbiomics and bacterial molecular genetics.

Previously, Natalie was a PDRA at the Institute for Sustainable Food where her research focused on soil microbiota and plant-microbe interactions in the context of sustainable, low input agriculture (from 2021). Before this Natalie was a PDRA at The University of Leicester working on a BBSRC Newton Fund Project: 鈥淩apid diagnostics and control strategies for enteric bacterial pathogens in backyard and commercial poultry production in Thailand and the Philippines鈥� (from 2018). She gained her PhD in Molecular Microbiology in 2018 from The University of Nottingham.